D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 66,395 446 World Ranking 11608 National Ranking 58

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

The scientist’s investigation covers issues in Breast cancer, Internal medicine, Endocrinology, Cancer research and Cancer. His Breast cancer course of study focuses on Bioinformatics and Drug resistance, Gene expression profiling and Comparative genomic hybridization. Per Eystein Lønning has researched Gene expression profiling in several fields, including DNA microarray, Breast cancer classification and Triple-Negative Breast Carcinoma.

His research on Internal medicine often connects related areas such as Oncology. His Endocrinology research incorporates themes from In vivo and Aminoglutethimide. His Cancer research research integrates issues from CHEK2, Carcinogenesis, Gene, Genotype and Metastasis.

His most cited work include:

  • Molecular portraits of human breast tumours (11695 citations)
  • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (8716 citations)
  • Repeated observation of breast tumor subtypes in independent gene expression data sets (4338 citations)

What are the main themes of his work throughout his whole career to date?

Per Eystein Lønning mainly focuses on Internal medicine, Breast cancer, Oncology, Endocrinology and Aromatase. The various areas that he examines in his Breast cancer study include Cancer research, Chemotherapy and Bioinformatics. His Cancer research study also includes

  • Gene and related Molecular biology,
  • DNA methylation that intertwine with fields like Methylation.

His studies in Oncology integrate themes in fields like Colorectal cancer, Gynecology, Adjuvant therapy and Pathology. He interconnects In vivo and Aminoglutethimide in the investigation of issues within Endocrinology. His Aromatase research incorporates elements of Megestrol acetate, Adjuvant and Pharmacology.

He most often published in these fields:

  • Internal medicine (76.05%)
  • Breast cancer (67.87%)
  • Oncology (43.92%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (76.05%)
  • Breast cancer (67.87%)
  • Oncology (43.92%)

In recent papers he was focusing on the following fields of study:

Per Eystein Lønning mostly deals with Internal medicine, Breast cancer, Oncology, Cancer research and Cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Mdm2. His Breast cancer research incorporates elements of Germline mutation, Estrogen and PTEN.

His Oncology research is multidisciplinary, incorporating elements of Chemotherapy, Case-control study, Tamoxifen, Ovarian cancer and Genotype. His research integrates issues of DNA methylation, Apoptosis and Downregulation and upregulation, Gene, microRNA in his study of Cancer research. His biological study spans a wide range of topics, including DNA microarray and Gene expression profiling.

Between 2014 and 2021, his most popular works were:

  • Subclonal diversification of primary breast cancer revealed by multiregion sequencing (492 citations)
  • Genomic Evolution of Breast Cancer Metastasis and Relapse (276 citations)
  • Genomic Evolution of Breast Cancer Metastasis and Relapse (276 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Per Eystein Lønning mainly investigates Internal medicine, Oncology, Cancer research, Cancer and Breast cancer. He has researched Oncology in several fields, including Quiescent state, Case-control study, Genotype, Hepatectomy and Colorectal cancer. His work carried out in the field of Cancer research brings together such families of science as Mutation, Primary tumor, Carcinogenesis and Transcription factor.

His Cancer research is multidisciplinary, relying on both Angiogenesis and Mitochondrion. The Breast cancer study which covers Germline mutation that intersects with CA15-3. His Aromatase inhibitor study combines topics from a wide range of disciplines, such as Antiestrogen, Estrogen and Combination therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Molecular portraits of human breast tumours

Charles M. Perou;Therese Sørlie;Michael B. Eisen;Matt van de Rijn.
Nature (2000)

19003 Citations

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Therese Sørlie;Charles M. Perou;Robert Tibshirani;Turid Aas.
Proceedings of the National Academy of Sciences of the United States of America (2001)

13276 Citations

Repeated observation of breast tumor subtypes in independent gene expression data sets

Therese Sørlie;Robert Tibshirani;Joel Parker;Trevor Hastie.
Proceedings of the National Academy of Sciences of the United States of America (2003)

6641 Citations

A Randomized Trial Of Exemestane After Two To Three Years Of Tamoxifen Therapy In Postmenopausal Women With Primary Breast Cancer.

R. C Coombes;E. Hall;L. J. Gibson;R. Paridaens.
The New England Journal of Medicine (2004)

2325 Citations

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

Jonathan R. Pollack;Therese Sørlie;Charles M. Perou;Christian A. Rees.
Proceedings of the National Academy of Sciences of the United States of America (2002)

1458 Citations

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

RC Coombes;LS Kilburn;CF Snowdon;R Paridaens.
The Lancet (2007)

1053 Citations

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Turid Aas;Anne Lise Børresen;Stephanie Geisler;Birgitte Smith-Sørensen.
Nature Medicine (1996)

926 Citations

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Jonathan R. Pollack;Charles M. Perou;Therese Sorlie;Ash A. Alizadeh.
Nature Genetics (1999)

762 Citations

Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation

Gro Vatne Røsland;Agnete Svendsen;Anja Torsvik;Ewa Sobala.
Cancer Research (2009)

742 Citations

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Jürgen Geisler;Ben Haynes;Gun Anker;Mitch Dowsett.
Journal of Clinical Oncology (2002)

698 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Per Eystein Lønning

Charles M. Perou

Charles M. Perou

University of North Carolina at Chapel Hill

Publications: 217

Anne Lise Børresen-Dale

Anne Lise Børresen-Dale

Oslo University Hospital

Publications: 214

Vessela N. Kristensen

Vessela N. Kristensen

Oslo University Hospital

Publications: 158

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 156

Ian O. Ellis

Ian O. Ellis

University of Nottingham

Publications: 137

Carlos Caldas

Carlos Caldas

University of Cambridge

Publications: 130

Mitch Dowsett

Mitch Dowsett

Breast Cancer Research Foundation

Publications: 128

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 122

Giuseppe Viale

Giuseppe Viale

University of Milan

Publications: 112

Christos Sotiriou

Christos Sotiriou

Université Libre de Bruxelles

Publications: 110

Emad A. Rakha

Emad A. Rakha

University of Nottingham

Publications: 108

Sunil R. Lakhani

Sunil R. Lakhani

University of Queensland

Publications: 108

Martine Piccart

Martine Piccart

Université Libre de Bruxelles

Publications: 102

Lajos Pusztai

Lajos Pusztai

Yale University

Publications: 101

Lars A. Akslen

Lars A. Akslen

University of Bergen

Publications: 89

Eric P. Winer

Eric P. Winer

Harvard University

Publications: 88

Trending Scientists

Mark Dredze

Mark Dredze

Johns Hopkins University

Marie Pierre Krafft

Marie Pierre Krafft

University of Strasbourg

Hong Chen

Hong Chen

Soochow University

Jun Guo

Jun Guo

Peking University

Neal M. Williams

Neal M. Williams

University of California, Davis

Bodo W. Reinisch

Bodo W. Reinisch

University of Massachusetts Lowell

Timothy A. Minshull

Timothy A. Minshull

University of Southampton

Diarmid Campbell-Lendrum

Diarmid Campbell-Lendrum

World Health Organization

Thomas M. Kündig

Thomas M. Kündig

University of Zurich

Sirpa Jalkanen

Sirpa Jalkanen

University of Turku

Christine Markham

Christine Markham

The University of Texas Health Science Center at Houston

Susan Nolen-Hoeksema

Susan Nolen-Hoeksema

Yale University

Larry S. Webber

Larry S. Webber

Tulane University

David R. Wood

David R. Wood

Monash University

Jens Newig

Jens Newig

Leuphana University of Lüneburg

Dhaval Dave

Dhaval Dave

National Bureau of Economic Research

Something went wrong. Please try again later.